Recent years have seen a flood of studies linking genetic variations to particular diseases, and companies are trying to parlay those discoveries into direct-to-consumer genetic tests. Navigenics mails its subscribers containers for saliva samples. When it gets the samples back, it uses microarrays–chips studded with fragments of DNA–to screen the subscribers’ DNA for genetic variations linked to 18 diseases, including Alzheimer’s and colon cancer. Such genetic screening has received little clinical evaluation, however, so whether it helps prevent disease is unclear.
Credit: Joshua Scott
These materials were meant to revolutionize the solar industry. Why hasn’t it happened?
Perovskites are promising, but real-world conditions have held them back.
Why China is still obsessed with disinfecting everything
Most public health bodies dealing with covid have long since moved on from the idea of surface transmission. China’s didn’t—and that helps it control the narrative about the disease’s origins and danger.
Anti-aging drugs are being tested as a way to treat covid
Drugs that rejuvenate our immune systems and make us biologically younger could help protect us from the disease’s worst effects.
A quick guide to the most important AI law you’ve never heard of
The European Union is planning new legislation aimed at curbing the worst harms associated with artificial intelligence.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.